Clinical trial
SAFE Study - Septal Pacing for Atrial Fibrillation Suppression Evaluation
NCT00419640 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT00419640 |
|---|---|
| Title | SAFE Study - Septal Pacing for Atrial Fibrillation Suppression Evaluation |
| Official title | Septal Pacing for Atrial Fibrillation Suppression Evaluation |
| Acronym | SAFE |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Device |
| Interventions | Pacemaker implantation with RA lead in LAS position, Pacemaker implantation with RA lead in RAA position |
| Enrollment | 385 |
| Start date | May 1, 2005 |
| Primary completion | Feb 1, 2012 |
| Completion | Nov 1, 2012 |
| First posted | Jan 9, 2007 |
| Last update posted | Feb 4, 2019 |
| Countries | Hong Kong |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: